Biote Corp BTMD.OQ reported quarterly adjusted earnings of 18 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -15 cents. The mean expectation of five analysts for the quarter was for earnings of 6 cents per share. Wall Street expected results to range from 3 cents to 10 cents per share.
Revenue fell 0.6% to $48.86 million from a year ago; analysts expected $49.54 million.
Biote Corp's reported EPS for the quarter was 10 cents.
The company reported quarterly net income of $3.19 million.
Biote Corp shares had risen by 3.7% this quarter and lost 32.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 15.6% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the professional information services peer group is also "buy"
Wall Street's median 12-month price target for Biote Corp is $6.50, about 40.6% above its last closing price of $3.86
This summary was machine generated from LSEG data August 7 at 01:25 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | 0.06 | 0.18 | Beat |
Mar. 31 2025 | 0.07 | 0.37 | Beat |
Dec. 31 2024 | 0.10 | 0.10 | Met |
Sep. 30 2024 | 0.09 | 0.33 | Beat |